Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has initiated coverage on the Company.
Copies of the new Zacks SCR report can be obtained via the following link:
Any opinions, judgments, estimates, or forecasts regarding the Company's historical or predicted performance or operations made by Zacks SCR are theirs alone and do not represent opinions, judgments, estimates, or forecasts of the Company or its management. The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.
About Zacks Small Cap Research
About Pressure BioSciences, Inc.
Forward Looking Statements
For more information about PBI and this press release, please click on the following website link:
Leverage Data for New Profit Centers
IoT Evolution #TECHSUPERSHOW Expo Hall Open